Lilly Humulin package label must designate Novo Nordisk's NovoPen trademarks, court rules.
Executive Summary
LILLY HUMULIN (HUMAN INSULIN) PACKAGE LABEL WILL BE MODIFIED to indicate that the NovoPen and NovolinPen trademarks referred to on the label are registered trademarks of Novo Nordisk, under a court order handed down by the U.S. District Court for the Southern District of New York. Lilly is "enjoined from distributing to wholesalers Humulin insulin cartridges in their current packaging which does not attribute ownership of" Novo Nordisk's trademarks, the Aug. 30 order states. The injunction does not effect products already shipped to wholesalers or retailers.